Hsbc Holdings PLC Has $68.12 Million Holdings in The Clorox Company (NYSE:CLX)

Hsbc Holdings PLC boosted its position in shares of The Clorox Company (NYSE:CLX) by 23.4% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 499,102 shares of the company’s stock after acquiring an additional 94,807 shares during the period. Hsbc Holdings PLC owned 0.40% of Clorox worth $68,124,000 at the end of the most recent quarter.

A number of other hedge funds also recently bought and sold shares of CLX. Elo Mutual Pension Insurance Co boosted its stake in Clorox by 13.4% during the 2nd quarter. Elo Mutual Pension Insurance Co now owns 11,609 shares of the company’s stock valued at $1,584,000 after purchasing an additional 1,375 shares during the period. Mercer Global Advisors Inc. ADV boosted its position in shares of Clorox by 7.7% in the second quarter. Mercer Global Advisors Inc. ADV now owns 13,768 shares of the company’s stock valued at $1,879,000 after acquiring an additional 980 shares during the period. Axxcess Wealth Management LLC grew its position in Clorox by 23.7% in the 2nd quarter. Axxcess Wealth Management LLC now owns 13,466 shares of the company’s stock worth $1,838,000 after purchasing an additional 2,582 shares during the last quarter. Edgestream Partners L.P. acquired a new stake in Clorox during the second quarter worth about $2,172,000. Finally, Moors & Cabot Inc. grew its holdings in shares of Clorox by 31.9% during the 2nd quarter. Moors & Cabot Inc. now owns 3,746 shares of the company’s stock worth $511,000 after purchasing an additional 905 shares in the last quarter. 78.53% of the stock is currently owned by institutional investors.

Clorox Price Performance

CLX opened at $162.00 on Friday. The company has a debt-to-equity ratio of 5.04, a current ratio of 1.03 and a quick ratio of 0.63. The company’s 50 day simple moving average is $148.60 and its 200-day simple moving average is $143.69. The Clorox Company has a one year low of $114.68 and a one year high of $169.09. The stock has a market capitalization of $20.12 billion, a P/E ratio of 83.94, a price-to-earnings-growth ratio of 3.29 and a beta of 0.40.

Clorox (NYSE:CLX) last released its earnings results on Thursday, August 1st. The company reported $1.82 EPS for the quarter, beating the consensus estimate of $1.54 by $0.28. The company had revenue of $1.90 billion during the quarter, compared to analysts’ expectations of $1.97 billion. Clorox had a return on equity of 281.12% and a net margin of 3.95%. Sell-side analysts anticipate that The Clorox Company will post 6.63 earnings per share for the current fiscal year.

Clorox Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, November 7th. Stockholders of record on Wednesday, October 23rd will be given a $1.22 dividend. The ex-dividend date of this dividend is Wednesday, October 23rd. This represents a $4.88 annualized dividend and a dividend yield of 3.01%. Clorox’s dividend payout ratio is currently 252.85%.

Wall Street Analyst Weigh In

A number of equities research analysts have weighed in on CLX shares. Argus upgraded shares of Clorox to a “hold” rating in a research note on Tuesday, June 4th. Wells Fargo & Company dropped their price target on shares of Clorox from $135.00 to $130.00 and set an “underweight” rating for the company in a research report on Wednesday, July 10th. Citigroup lifted their price objective on Clorox from $165.00 to $170.00 and gave the company a “neutral” rating in a report on Friday, September 6th. BNP Paribas raised Clorox to a “strong sell” rating in a report on Friday, September 6th. Finally, DA Davidson restated a “neutral” rating and set a $153.00 target price on shares of Clorox in a research report on Friday, September 6th. Six investment analysts have rated the stock with a sell rating and thirteen have assigned a hold rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Hold” and a consensus price target of $143.50.

Insider Buying and Selling

In other Clorox news, EVP Angela C. Hilt sold 1,733 shares of the stock in a transaction dated Friday, September 6th. The stock was sold at an average price of $165.52, for a total value of $286,846.16. Following the transaction, the executive vice president now owns 13,471 shares of the company’s stock, valued at $2,229,719.92. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. 0.51% of the stock is owned by insiders.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.